(Q69404886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

Y Tokuda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

N Ebina

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

S H Golub

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

1 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

205-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

1 October 2019

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Functional studies on the precursors of human lymphokine-activated killer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Regulatory effect of interferon on T cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Sequential expression of genes involved in human T lymphocyte growth and differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Human leukocyte interferon produced by E. coli is biologically active

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

The regulatory effect of adherent cells on lymphokine activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Role of proliferation in LAK cell development

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Effect of Recombinant Alpha Interferon on NK and ADCC Function in Lung Cancer Patients: Results from a Phase II Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Purified interleukin-2 induces proliferation of fresh human lymphocytes in the absence of exogenous stimuli

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Universal rosetting reagent for the detection of human cell surface markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

The role of transferrin in natural killer cell and IL-2-induced cytotoxic cell function

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Molecular cloning of human interleukin 2 cDNA and its expression inE. coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Analysis of the steady state binding, internalization, and degradation of human interferon-alpha2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Effects of recombinant interleukin-2 on resting human T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Inhibition of transferrin receptor expression by interferon-alpha in human lymphoblastoid cells and mitogen-induced lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Close link between reduction of c-myc expression by interferon and, G0/G1 arrest

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Response of resting human peripheral blood natural killer cells to interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Generation of lymphokine-activated killer cells does not require DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2598190

12 December 2020

Identifiers

DOI

10.1007/BF01665006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2598190%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 October 2019

1048789018

0 references

1 reference